Michael Jefford
Peter MacCallum Cancer Centre, VIC, Australia
- This delegate is presenting an abstract at this event.
Professor Michael Jefford is a Consultant Medical Oncologist at the Peter MacCallum Cancer Centre. He is the Director of the Australian Cancer Survivorship Centre and leads the Survivorship and Living Well After Cancer research program with the Department of Health Services Research. He is also a Professorial Fellow at the University of Melbourne.
Professor Jefford completed his medical oncology training (FRACP) in 1999 and holds a PhD (2002) and Graduate Certificate in University Teaching (2013) from the University of Melbourne and Masters degrees in Health Services Management (2003) and in Public Health (2006) from Monash University. He is a Graduate of the Australian Institute of Company Directors.
His major clinical focus is on the management of people with gastrointestinal cancers. Most of his research has a cancer survivorship focus. He has been awarded A$23m in grant funding as a chief / principal investigator. He has numerous leadership roles including being a Board Member (Director) of the Clinical Oncology Society of Australia (COSA). He leads the survivorship study group with the Multinational Association of Supportive Care in Cancer, and has held similar roles with COSA, the American Society of Clinical Oncology and the International Psycho-Oncology Society.
He has convened multiple successful survivorship conferences. He has contributed to more than 250 publications (as of June 2024) and presented at numerous international meetings covering clinical oncology, survivorship, psycho-oncology and cancer control broadly.
Presentations this author is a contributor to:
Translating Research Into Practice: The Healthy Living after Cancer Partnership Project (#49)
4:45 PM
Elizabeth Eakin
Best of the Best Orals - Supportive Care
Does the prevalence of anxiety and depression for diffuse large B-cell lymphoma cancer survivors change over time: a prospective study (#384)
3:00 PM
Devesh V Oberoi
Posters 2
A randomised controlled trial to improve enrolment to cancer clinical trials (#104)
2:15 PM
Cat Parker
Best of the Best Orals - Health services